MedPath

Hemolate

Brand Name: Hemolate

Generic Name: Heparin (as sodium)

Active
Registration Number

BRP-136-01

Dosage Form

Solution for Injection (I.V./S.C.)

Issuance Date

June 30, 2024

Expiry Date

May 10, 2029

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength1000 I.U./ml (5000 I.U./5ml)
PackagingUSP Type I amber glass vial with blue flip-off seal x 5mL / (Box of 1's and 10's)

Classification

C
Classification
Prescription Drug (Rx)
P
Pharmacologic
Antithrombotic Agents
A
Application
CLIDP Conversion
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

Heparin (as sodium)Active
Monograph: Heparin, bovine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform